Pharma · Private company
Ferring Pharmaceuticals
Track this companyFree. Adds Ferring Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials255 recruiting or active
Pipeline programs24From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline24
- ADSTILADRINPhase 3 · Superficial Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- DegarelixPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · Non-muscle Invasive Bladder Cancer With Carcinoma in SituClinicalTrials.gov · fetched Nov 12, 2026
- Follitropin deltaPhase 3 · Infertility, FemaleClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 3 · Non-muscle Invasive Bladder Cancer With Carcinoma in SituClinicalTrials.gov · fetched Nov 12, 2026
- Nadofaragene FiradenovecPhase 3 · Non-muscle Invasive Bladder Cancer With Carcinoma in SituClinicalTrials.gov · fetched Nov 12, 2026
- Nadofaragene FiradenovecPhase 3 · Intermediate Risk Non-Muscle Invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 3 · Non-muscle Invasive Bladder Cancer With Carcinoma in SituClinicalTrials.gov · fetched Nov 12, 2026
- RBX2660Phase 3 · Clostridium Difficile Infection RecurrenceClinicalTrials.gov · fetched Nov 12, 2026
- CLENPIQPhase 2 · Bowel PreparationClinicalTrials.gov · fetched Nov 12, 2026
- FE 992097Phase 2 · Hyperphagia in Prader-Willi SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- FE 999049Phase 2 · Male Idiopathic InfertilityClinicalTrials.gov · fetched Nov 12, 2026
- MerotocinPhase 2 · Preterm DeliveryClinicalTrials.gov · fetched Nov 12, 2026
- MIRALAXPhase 2 · Bowel PreparationClinicalTrials.gov · fetched Nov 12, 2026
- Nadofaragene FiradenovecPhase 2 · Low-grade Upper Tract Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- SemapimodPhase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SENNAPhase 2 · Bowel PreparationClinicalTrials.gov · fetched Nov 12, 2026
- CarbetocinPhase 1 · Postpartum HemorrhageClinicalTrials.gov · fetched Nov 12, 2026
- LutrepulsePhase 1 · AmenorrheaClinicalTrials.gov · fetched Nov 12, 2026
- Microbiota capsulePhase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- Microbiota suspensionPhase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- ADSTILADRINBladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- nadofaragene firadenovecBladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- REBYOTA™Recurrence of Clostridium Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA TrialPHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07332351 · fetched Nov 12, 2026
- A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod PumpPHASE1 · WITHDRAWN · started Sep 12, 2025ClinicalTrials.gov NCT07152730 · fetched Nov 12, 2026
- Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal PelvisPHASE1_PHASE2 · RECRUITING · started Jun 12, 2025ClinicalTrials.gov NCT06668493 · fetched Nov 12, 2026
- Fast Track to FertilityNA · COMPLETED · started Apr 25, 2025ClinicalTrials.gov NCT07154888 · fetched Nov 12, 2026
- Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerPHASE3 · RECRUITING · started Oct 1, 2024ClinicalTrials.gov NCT06510374 · fetched Nov 12, 2026
- A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerPHASE3 · RECRUITING · started Oct 1, 2024ClinicalTrials.gov NCT06545955 · fetched Nov 12, 2026
- A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.PHASE4 · WITHDRAWN · started Jun 17, 2024ClinicalTrials.gov NCT06390111 · fetched Nov 12, 2026
- A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative ColitisPHASE1 · WITHDRAWN · started Mar 12, 2024ClinicalTrials.gov NCT06260267 · fetched Nov 12, 2026
- ADSTILADRIN Early Utilization and Outcomes in the Real World SettingTERMINATED · started Sep 15, 2023ClinicalTrials.gov NCT06026332 · fetched Nov 12, 2026
- REBYOTA™ Prospective RegistryCOMPLETED · started Jun 19, 2023ClinicalTrials.gov NCT05835219 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy SubjectsPHASE1 · COMPLETED · started May 25, 2023ClinicalTrials.gov NCT05924321 · fetched Nov 12, 2026
- A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile InfectionPHASE3 · COMPLETED · started Apr 21, 2023ClinicalTrials.gov NCT05831189 · fetched Nov 12, 2026
- A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)PHASE2 · TERMINATED · started Aug 16, 2022ClinicalTrials.gov NCT05403476 · fetched Nov 12, 2026
- Study Assessing CLENPIQ as Bowel Preparation for Pediatric ColonoscopyPHASE1_PHASE2 · RECRUITING · started Jun 23, 2022ClinicalTrials.gov NCT04113382 · fetched Nov 12, 2026
- Merotocin in Mothers With Inadequate Milk Production and Infants Delivered PrematurelyPHASE2 · TERMINATED · started May 28, 2021ClinicalTrials.gov NCT02545127 · fetched Nov 12, 2026
- Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate CancerEARLY_PHASE1 · COMPLETED · started Feb 25, 2020ClinicalTrials.gov NCT04301414 · fetched Nov 12, 2026
- Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)PHASE3 · COMPLETED · started Oct 29, 2018ClinicalTrials.gov NCT03738618 · fetched Nov 12, 2026
- Trial of ADT and SBRT Versus SBRT for Intermediate Prostate CancerPHASE3 · TERMINATED · started Mar 28, 2017ClinicalTrials.gov NCT03056638 · fetched Nov 12, 2026
- Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.PHASE2 · COMPLETED · started Mar 1, 2017ClinicalTrials.gov NCT03069937 · fetched Nov 12, 2026
- ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)PHASE3 · COMPLETED · started Sep 19, 2016ClinicalTrials.gov NCT02773849 · fetched Nov 12, 2026
- Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi SyndromePHASE2 · COMPLETED · started Jan 20, 2014ClinicalTrials.gov NCT01968187 · fetched Nov 12, 2026
- Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical ProstatectomyPHASE2 · COMPLETED · started Dec 18, 2013ClinicalTrials.gov NCT02020070 · fetched Nov 12, 2026
- Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate CancerNA · COMPLETED · started Feb 24, 2012ClinicalTrials.gov NCT01542021 · fetched Nov 12, 2026
- Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate CancerPHASE2_PHASE3 · COMPLETED · started Mar 1, 2005ClinicalTrials.gov NCT00117286 · fetched Nov 12, 2026
- Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's DiseasePHASE2 · COMPLETED · started Dec 1, 2002ClinicalTrials.gov NCT00740103 · fetched Nov 12, 2026